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PAGET (1958) AND WALPOLE (personal communication) found that the ad-
ministration of 4-ethvlsulphonylnaphthalene-l-sulphonamide (HPA) to rats of
their closed random-bred Wistar colony induced hyperplasia of the urinary tract
epithelium. The mechanism of its production was not elucidated although it was
thought that the phosphatic crystalluria, which resulted from the ingestion of
the chemical, might be involved. These workers obtained marked hyperplasiaby
the dailv aclministration of 30, 60 or 120 mg./kg. body weight five times a week
for S weeks, but found that as little as 0-01 per cent of the chemical in the diet
(approximatelv I mg. daily) produced crystalluria and some hvperplasia.
This paper deals with the effects of HPA in various species, the effect of
leiigth of exposure on the degree of hyperplasia and whether or not the hyper-
plasia is reversible. The action of six similar compounds on the urinarv tract
epithelium of mice has also been examined.
AIATERIAL AND A111',THODS
C'hemical.s.-4-ethvlstilphonvlnal)hthalene-i-stilphonamide (HPA) wasprepared
by Dr. D. B. Clavson, bv the method ofBrimelow and Vasey (1958). This chemical
will be referred to as the hvperplastic agent or HPA. Six relate(I chemicals were
also prepare(I bv the same method. Their chemical iiame, striieture, melting point
aiid abbreviation are (liven in Table 1.
E.rj)erin?evta1, aninwls
Mice ofthree inbredstraiiis, 8-12 weeks old, were tised for feedingexperiments.
TlieyNN,erewhitelabel(Leeds)orWI.,L,CBAandStrongA. Ailthreestrainswere
emploved for testing RPA and H6, Strong A and .AVLL for HI., H3 ai-id H4, and
Strong A on-ly for H2 and 1-1115.
Ratsbelonged to a closed colonv ofalbinos husbanded in Sheffield andorigilially
derived from Wistar stock. Each.'rat weighed _200-2,50 g. at the start.
Rabbit-s belonged to a mixed stock bred in the laboratorv. They weiglied
4i-6 lb. at the start.
Guinea-I)ig-s were obtained from a local dealer or from the laboratory stock,
and weighed 250-400 o,. at the start.
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TABLE I.-De8cription of the Chemical Compound8 Under InVe8tigatiOn
Melting
Chemical name Structure point Abbreviation
S02NH2
Isulphonylnaphthalene-l- 198-0 HPA
1phonamide
4-ethyl
Sul
SOAH5
802NH2
S02CH(CH,)2
S02NH2
S02C3H7
S02NH2
S02CH3
S02NHCH3
11
SOAH5
CH2-CH2
S02N CH2
CH2-CH2
SOAH5
S02NH2
1.11
4-isoprophylsulphonylnaphthalene-l-
sulphonamide
4-n-propylsulphonylnaphthalene-l-
sulphonamide
4-methylsulphonylnaphthalene-l-
sulphonamide
N-methyl-4-ethylsulphonylnaphthalene-I -sulphonamide
N-piperidyl-4-ethylsulphonylnaphthalene-l- sulphonamide
198.5-
200- 5
189-0-
190.0
140- 0-
141-0
135- 0-
136- 0
101.0-
102- 0
184- 0-
185- 0
Hl
H2
H3
H4
H5
H6 4-ethylsulphonylbenzene-l-sulphonamide
S02C2H5
DOg8were mongrels bought from a dealer, and weighed 181 and 22 lb. at the 2
start.
All animals received food and water ad lib.
Methods of administration and doses of the, chemicals in different animals
Mice.-The chemicals were incorporated in the diet in a concentration of
100 mg./kg. (0-01 per cent). Powdered rat cake (obtained from the Northern
Agricultural Society, Aberdeen) was mixed thoroughly with an acetone solution112 K. P. SEN GUPTA
of the chemical and made into a thick paste with water. This paste was subse-
quently dried in a hot air oven at 56' C. for 48 hours.
Rats.-In the first trial the chemical (100 mg.) was added to the diet (I kg.)
in the usual way. Thereafter, the chemical was made into a thick suspension of
40 mg./ml. of arachis oil. 0-2 ml. of the suspension (8 mg. chemical) was given by
stomach tube under light ether anaesthesia to each rat six times a week for 15
weeks.
Rabbits.-O-5 ml. of a suspension of 100 mg. chemical/ml. arachis oil (50 mg.
chemical) was given by stomach tube under light ether anaesthesia six times a
week for 15 weeks.
Guinea-pigs.-The suspension of the chemical was made in the same concen-
tration as for rats but the dose was 20 mg. in 0-5 ml. oil, which was given by
stomach tube under light ether anaesthesia six times a week for 15 weeks.
Dogs.-The chemical was given by mouth in powder form in a gelatin capsule.
In one dog the dose was 120 mg. per day six times a week for 5 weeks. This dose
was similar to that in mice in relation to the bodv wei-aht. In the other dog, the
dose was doubled; this animal received 250 mg./day six times a week for 4 weeks,
followed by 500 mg./day six times for another week before it was killed.
Technique ofpost mortem examination
Mice were killed by ether. The urinary bladder was distended by injecting
Bouin's fluid per urethram. The bladder, kidneys and ureters were dissected out
en bloc and fixed intact on a thin sheet of cork. The latter was put in a large
volume offixative for 24 hours. The bladder was bisectedvertically atright angles
to the sagittal plane in order to obtain the intravesical portion of one or both
ureters in the section. The kidneys were bisected in a plane which allowed the
renal pelvis and upper end of the ureter to be included in the section.
Rats, rabbits, guinea-pigs and dogs were killed by ether, except the dogs, which
received intravenous nembutal. The urinary bladder was distended with formol
saline and the neck of the bladder tied by cotton thread. The kidneys with at-
tached ureters were dissected out, fixed on a thin sheet of cork and put in a large
volume of fixative. Sections were cut from different portions of the bladder, the
ureteric orifice of the bladder, the mid portion of the ureters and from the renal
pelvis and renal parenchyma. All the sections were stained by haematoxylin and
eosin and, when required, by the periodic acid-Schiff method, Alcian blue and
von Kossa's method for calcium.
RESULTS
Experiment I-Testing of HPA and H3 in different -strains of mice
After a preliminary trial, which showed that HPA did induce urinary tract
epithelial hyperplasia in the mouse, an experiment was planned as shown in
Table 11. In both male and female mice of the strains WLL and Strong A, there
was urinary tract epithelial hyperplasia and the effect could be demonstrated as
early as 5 weeks after continuous administration of the chemicals. The effect
persisted, and became more advanced as the duration of the treatment increased.
A few CBA mice appeared to respond in the early weeks, but not in the later part
of the experiment. The impression was gained that H3 was rather more active
than HPA.113 HYPERPLASIA OF URINARY TRACT EPITHELIUM
TABLIE H.-Continuous Treatment of Mice with HPA and H3
Number
Number dying
at during ex-
Chem- Strain start periment
ical r--"-.
M F M F
HPA . WLL . 15 8 . 3 2 .
Strong A .14 14.25 .
CBA . 20 8 . 6 1 .
Number kiBed (weeks)*
1
5 10 15 20 25 30 35 40 1
2 2 2 2 2 2 3 3 .
2 2 2 2 3 3 3 4 .
2 2 2 2 3 3 3 4 .
Hyperplasia of
urinary tract
epithelium
Ir I
Bladder Ureter Pelvis
H3 . WLL . 12
Strong A . 16
8 . 2 1 . 2 2 2 2 2 2 2 2 . +
8 . 3 5 . 2 2 2 2 2 2 2 2 . +
* Animals dying spontaneously not included.
+ = Present.
± = Initial response not maintained.
Apreliminary trial in a few mice had shown that thehyperplasia was reversible
if the treatment was discontinued up to 10 weeks. In order to study this further,
in addition to the mice shown in Table 11, two mice were removed from the
experiment at 20, 25, 30, 35 and 40 weeks and weregiven a normal diet for 7 days.
In the HPA experiment this was done in all three strains; with H3 it was done
only in Strong A mice, except that 2 mice of the WLL strain were removed at
35 and 40 weeks. In all the mice thus treated, the hyperplasia subsided within
one week following the cessation of treatment, but when organic change such as
hydronephrosis or hydro-ureter was present this persisted.
TABLIF, III.-Treatment ofRats, Rabbits and Guinea-pigs with HPA and H3
Hyperplasia of
urinary tract
epithelium
Blad- Ure- Renal
der ter pelvis
Number
at
start
Species M F
Rat 6 0
Number
imber killed
ying (weeks)*
iring
.riment 2 10 15
0 2 2 2
Nu]
Metho& of d)
adminis- du
tration expei
Chem-
ical
HPA
Daily
dose
0.01%
in diet
8 mg.
50 mg.
20 mg.
Daily
in diet
Bystomach
tube x 6
per week
6
Rabbit 2
Guinea-pig 3
0
4
3
0
2
2
2
1
1
2
1
1
2
2
2
9
H3 Rat 6 0 0-01% Daily
in diet in diet
6 0 8 mg. By stomach
Rabbit 3 3 50 mg. tube x 6
- Guinea-pig 4 2 20 mg. per week
0 2 2 2
1
3
2
I
I
I
2
1
1
2
1
2
Animals dying spontaneously not included.
Experiment 11-Testing of HPA and H3 in rats, rabbits, guinea-pigs and dogs
(Table III)
The trial dose of 0-01 per cent in the diet was ineffective in rats, but when it
was increased to 8 mg. six times per week (i.e. seven-fold) for periods from 2-15
weeks a positive response was obtained with both compounds. The response in
the rabbit was doubtful with.the dose.used andguinea-pigs wererefractory.Hyperplasia ofurinary tract
epithelium
A
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In addition, HPA only was tested in the dog for a period of 5 weeks. In the
first dog, the dose was calculated to be proportionate to that used for mice.
When this was ineffective, the dose was doubled for 4 weeks and quadrupled for
one week. Even so, no hyperplasia was obtained. The results are summarised
in Table IV.
TABLE IV.-SummaryofContinuous Treatment with HPA in Different Species
for Varying Lengths of Time
Number Period of
at observation
start (weeks)
79 5-40
12 2-15
6 2-15
6 2-15
2 5
r-..
Bladder Ureter Renal pelvis Species
Mice .
Rats .
Rabbits
Guinea-pigs
Dogs
.
Experiment III-Testing ofHI, H2, H4, H5 and H6
These compounds were tested on mice of one or both of the strains WLL and
Strong A in the dose found to be effective for HPA and H3 (Table V). H2, H4,
TABLE V.-Treatment ofDifferent Strains of Mice with HI, H2, H4, H5 and H6
in a D08e of 0-01 per cent in Diet
Number
dying
during ex-
periinent
M F
1 1
1 2
6 5
1 0
4 3
0 0
2 1
10 1
9 5
Hyperplasia of
urinary tract
epithelium
Renal
pelvis
Number
at
Strain start
r--111-.
M F
WLL 4 9
3trong A 14 10
3trong A 13 14
WLL 7 0
3trong A 14 10
3trong A 6 0
WLL I1 6
;trong A 27 10
CBA 15 9
Chem-
ical Number killed (weeks)*
5 10 15 20 25 30 35 40 Bladder Ureter
2 2 2 2 2 1 + +
2 2 2 2 2 3 3 4 + +
2 2 2 2 2 2 2 2
2 2 . 2 .. .. .. ..
2 2 2 2 2 2 2 3
2 2 2
2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 .. .. .. 2 2
Hi
8
H2 .8
H4
8
H5 .s
H6
s
* Animals dying spontaneously not included.
+ = Present.
= Absent.
H5 and H6 were completely inactive, but it is to be noted that as H5 was avail-
able only in small quantity, the test was not continued beyond 15 weeks. H6
was also tested in CBA mice. Themortality washigh, but in 6 mice killed between
5 and 15 weeks and 4 at 35-40 weeks no hyperplasia was observed.
The, structure of the, normal urinary tract epithelium of the mouse
The bladder is.lined by transitional epithelium 2-3 layers thick. The cells of
the basal layer tend to be vacuolated, while the cytoplasm ofthe superficial layer
is faintly eosinophilic and granular. The funnel-shaped renal pelvis surrounds the
single papilla. Near the fornix it is lined with stratified transitional epithelium,115 HYPERPLASIA OF URINARY TRACT EPITHELIUM
which becomes thicker (4-5 layers) as the entrance to the ureter is reached. The
renal papilla fills almost the whole of the pelvis and is covered with a single layer
of cuboidal epithelium (Fig. 1).
The ureter is linedby transitional cell epithelium 3 to 4 layers thick. The basal
cells are vacuolated, while the superficial cells have faintly granular eosinophilic
cytoplasm. When the ureter is partially contracted, even the folded eipthelium
has a similar appearance (Fig. 2).
Changes in the Urinary Bladder, Kidney and Ureter in the Mouse and
Rat Following Continuous Administration of the Active Chemicals
31'acroscopical
Urinary bladder
In the rat, a few fine crystals were seen inside the bladder when the higher
doses were employed. In the mouse, tiny white crystals were frequently found.
In some cases, large multifaceted stones were present and caused distension of
the organ. There was no correlation between the presence of the stone, large or
small, and hydronephrosis, which was frequently unilateral rather than bilateral.
Moreover, similar crystals or stones were equally frequent in the bladders of the
mice treated with the inactive compounds.
Renalparenchyma
In both the rat and the mouse, the gross changes could be divided into two
main types: (i) hydronephrosis of either early pelvic or late severe type, and (ii)
scarred and/or contracted kidneys.
(i) Hydronephrosis.-In the rats treated with HPA and H3 there was only
one instance ofright-sided pelvic type ofhydronephrosis at the end of 15 weeks.
In the mouse, unilateral hydronephrosis was often observed even in the early
stages of administration of the chemicals and as early as 5 weeks after the start
of treatment. Where the hydronephrosis was bilateral, the right kidney was
usually more severely affected than the left. The severe type of hydronephrosis
was less frequent and was observed only in the late stages of the experiments. With inactive chemicals these changes were infrequent.
(ii) Scarred andlor contracted kidneys.-Scarring of a portion of one or both
kidneys was rarely observed before 10-15 weeks. Sometimes the whole kidney
was reduced in size and had afinelygranular surface. The renal andpelvic changes
were observed simultaneously in some instances, causing difficulty in classifying the lesions, which were then recorded under the predominant lesion.
(iii) Ureter.-The upper portion of the ureter was usually dilated if the pelvic type ofhydronephrosis was present. Sometimes the whole ureter was affected on
one or both sides. Stones were not found in the ureter.
The results of the macroscopical observations are summarised in Table VI.
Microscopical
Urinary bladder
The changes in the urinary bladder of the rat and the mouse could be sub-
divided into three varieties :
(i) Focal epithelial hyperplasia.-This usually affected different areas of the
same bladder and appeared to be the earliest change following administration of116 K. P. SEN GUPTA
TABLE VI. Macroscopical Appearance of the Urinary Bladder, Renal Parenchyma
and Ureter inMice after Continuou8 Treatment with HPA, H3 and HI
iNumber State ofkidneys
dying
Number during Urinarv
Chem- at experi- bladder Hvdro- Scarred
ical Strain start ment nephrosis and/or Ureter-s
Coii- con-
M F M F Nori-i-ial ei-etion Normal Pelvic Severe tracted TKormal Dilated
HPA Strong A 14 14 2 5 9 12 14 16 6 6 26 16
WLI, 15 8 3 2 8 10 16 10 8 25 1 1
H3 Strong A 16 8 3 5 6 W 14 8 4 6 20 12
WLL 12 8 3 1 7 9 16 8 3 5 22 10
H I Strong A 14 1O 1 2 10 1 1 16 1 1 8 7 23 19
WLI, 4 9 I 1 3 8 8 6 3 5 14 8
EXPLANATION OF PLATES
Fic.,. I.-Norinal inouse retial pelvis. Tfie papilla is covet-ed by a siiigle layer of cuboidal
epithelium. Ttie parietal wall of the pelvis is lined by stratified traiisitional epithelium
which becoiiies tliieker as the top of the ui-etor is approached. x45.
Fi(;. 2.-Mid portion of norinal inouse ureter. The basal cells are vacuolated while the super-
ficial cells ai-e fitielv grariular. x 65.
FIG. 3.-In this aii(i ttie succeeding figui-es tfle bladder epitheliun-i is upperniost. Urinary
bladder froii-i Strong A mouse after 5 weeks of HPA in diet. There is transition from liormal
epithelium oii the right to aii area of focal hylperplasia several layei-s thick on the left.
Ttlere is slight oedeiiia of the subepitlielial tissues aiid scanty- eellulal- infiltratioii. Ttie
i-iiusele is noi-inal. x 45.
FIG. 4.-Mouse bladder aftei- 15 weeks of HPA in diet. The whole epitheliun-1 is 5-8 layers
thick. There is oedeina of the subepithelial tissues. x 45.
FIG. 5.-Mouse bladder after 20 weeks of' HPA in diet. Tliei-e are two papillary projections
of epitlieliiim several lavers tliiek, one witli and the other without, a core. T.ese are part
of a getieral hvperplasi. (well seen oti the left) and at-e not tumours. x 100.
Fic.. 6.--Bladder fi-om rat after 15 weeks of HPA by stoiiiach tube, sliowii-ig diffuse epithelial
hyperplasia leadiiig to folding, and slight subepithelial oedema. x 33.
Fic.. 7.--Mouse bladder showitig diffuse hyperplasia, 5- 6 layers thie'k. Nuclei are hYperchro-
iiiatic and there are bizarre nuclei aiid occasional mitoses. x 125.
Fi(:,,. 8.---.Nlouse bladder after 40 weeL-s of HI In diet, showing traiisitional cell papilloma with
formation of luii-Liiia. x 20.
Fio,. 9.-Mouse bladder after 40 weeks of H3 in diet, showiiig exte'nsive transitional eell
careinorna. x 40.
Fi(.,. IO.-Rat kidney after 15 weeks of HPA by stoinaeli tube. There is a cast of caleitim salts;
in a reiial tubule in the centre, witli partial necrosis of the epithelial cells. There is also
arnorphous deposit in the adjaceiit tubule below. x 125.
FIG. 1. I.-Kidnev fi-oi-n Strong A mouse after 20 weeks of HPA in diet. Tllere is a lanlinated
cast of calcium salts in the tubule near the space (above) and also a collection ofIN-inphocNItes
in the adjoining area. x 125.
FIG. 12.--Mouse kidney after 20 weeks of HPA in diet, showing cortex to left and niedulla to
right. There is widespread deposition of calcium salts, which appear black, in the lumen of
both cortical aiid medullary tubules. x 20.
FiG. 13.-Section of whole mouse kidney after 15 weeks of HPA in diet. Pelvic tvpe ofhydro-
nephrosis with compressioti of the papilla atid general dilatation of the tubu.les. There is
marked epithelial hvperplasia of the renal pelvis. x 12.
FIG. 14.-High power view of the same renal pelvis as in Fig. 13. There is uniforin epithelial
hyperplasia 6-8 layers thick at the enti-ance to the uret-er. x 45.
FIG. 15.--Mouse bladder near the orifice of the ureter. The ureteric epithelium shows marked
hyperplasia, causing a slit-like lumeti, while the epithelium of the bladder (on left) shows
difftise byperplasia and there is also oedeina of the subepithelial tissues. x 33.
Fic- 16.-Dilated ureter from a mouse after 20 weeks of HPA, at the same magnification as
Fig. 2. There is uniform epithelial hyperplasia with desquamated epithelial eells within the
luinen and gross dilatation of the ureter. x 65.Vol. XVI, No. 1. BRITISH JOUR11TAL OF CANCER.
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the chemicals. In the preliminary trial, initial necrosis of the epithelium was
observed after two weeks, and focal hyperplasia as early as 3 or 4 weeks. The
latter was, however, more uniformly observed 5 weeks following the start of treat-
ment. Transition could be seen from a normal epithelium of 2 or 3 layers thick
to an area of 5 or 6 layers thick in a well distended bladder. The subepithelial
tissues usually showed some oedema with scanty cellular infiltration (Fio'. 3). In
some instances, severe inflammation affected the entire bladder wall or focal areas
of lvmphocytic infiltration were seen in the subepithelial tissues. There was no
correlation betweenhyperplasia oftheepithelium andthe presence ofinflammation.
Indeed with H4, severe inflammation of the bladder wall was often observed
without any evidence of consistent hyperplasia.
(ii) Diffu8e epithelial hyperplasia.-This affected the entire urinary bladder,
the epithelium being 6 or 8 layers thick. It was associated with oedema of the
subepithelial tissues (Fig. 4). In more severe lesions, there were papillary excre-
scences of the increased layers either with or without a core (Fig. 5). The basal
cells sometimes grew into the subepithelium due to folding (Fig. 6). The nuclei
werehyperchromatic (Fig. 7) and occasional mitoses were observed. These changes
were seen in rats after 15 weeks and mice after 20 weeks and persisted as long as
the chemicals were administered. There was, however, no correlation between
the degree ofhyperplasia and the length of the administration of the chemical.
(iii) Papilloma and carcinoma. There were two papillomas with HI and one
carcinoma with H3 after 40 weeks of continuous administration. The papillomas
were transitional cell in type with the formation of acini (Fig. 8). One papilloma
was situated on the lateral wall between the dome and the neck and the other was
at the dome of the bladder. Carcinoma affecting two areas in the same bladder
was present in one mouse treated with H3. This was also transitional cell in type
with infiltration of the subepithelial tissue as far as the muscle layer but not
invading it (Fig. 9).
Renalparenchyma
There were three types of change in the renal parenchyma in the rat and
mouse.
(i) Tubular degeneration and/or depo8ition of calcium.-These changes occurred
either simultaneously or separately. Deposits of globular amorphous calcium
were seen in the convoluted and distal tubules, either in the early or late stages of treatment. When these occluded the lumen, there was concomitant necrosis of
the epithelial cells with subsequentregeneration. Some ofthese deposits appeared laminated (Fig. IO and I1). Similar depositions of calcium salts were observed
in the renal papilla and led to necrosis of the overlying epithelium. Subsequent
regeneration could be seen around such areas. In some instances calcium depo- sition was remarkably heavy in the corticomedullary areas but in others it was
irregularly distributed in the parenchyma (Fig. 12).
(ii) Pyelonephriti8.-The deposition of calcium salts in the tubule seemed to
initiate an interstitial inflammation. This was focal or diffuse, affecting simul-
taneously different parts of the same kidney and resulting in scarred or small
contracted kidneys. Sometimes a scarred kidney was observed without any de-
position of calcium salts but usually associated with hydronephrosis.118 K. P. SEN GUPTA
(iii) Hydi-onephrotic atrophy.-In the early pelvic type of hydronephrosis, the
parenchymal change consisted of focal dilatation of the collecting tubules, but
sometimes other parts of the nephron were affected. Later on, the renal papilla
was gradually compressed and more generalised tubular dilatation of both cortex
and medulla took place (Fig. 13). In this stage frequentlv there was associated
interstitial inflammation especially in mice treated for 15 weeks and more.
Renalpelvis and ureter
In some mice epithelial hyperplasia 7-8 layers thick occurred at the upper end
of the ureter and caused the early pelvic type of hydronephrosis (Fig. 14). In
others, this hyperplasia affected the whole ureter, resulting in narrowing of the
lumen into a, thin slit (Fig. 15). Similarhyperplasia was seen even in dilated ureters
(Fig. 16).
DISCLTSSION
The initial observation ofWalpole (personal communication) and Paget (1958)
that 4-ethylsulphonylnaphthalene-l-sulphonamide (HPA) induces hyperplasia of
urinary tract epithelium has been confirmed. In the present experiments it was
shown that hyperplasia was caused by repeated doses of an amount of chemical
mrhich the animals tolerated well and that dosing had to be continued until the
animals were killed. The hyperplasia subsided if an interval. of one week occurred
between the cessation of the treatment and death. The epithelium of the bladder
was more uniformly affected than that of either the renal pelvis.or ureter, but if
the changes were present in two or more sites, tliev seemed to arise concomitantly
rather than by spread from the bladder through the ureter to the pelvis. The
hvperplasia could be the primary and only change observed, or it could follow
initial necrosis or be associated with subepithelial oedema and inflammation. In
the kidney parenchyma, the changes were similar to those observed with other
siilphonamides, iiamely, tubular degeneration and calcification with an iiitense
inflammatorv reaction (Antopol et al., 1941).
The hyperplastic effect was most apparent in the mouse, but the rat and
possibly the rabbit were also affected. No response was observed in the guinea-pig
or, in experiments on oiily two animals, in dogs. Mice of the Strong A and white
label (Leeds) strains were equally affected, whereas those of the CBA strain were
less sensitive, the renal tract epithelium undergoing mild hyperplastic changes
onlv, which did not become more intense even when treatment was continued for
40 weeks. The sexes were equally affected in all cases.
Six analogues of the hvperplastic agent (HPA) were tested, of which two were
active, namely 4-methylsulphonylnaphthalene-l-sulphonamide (H3) and 4-isopro-
pylsulphonylnaphthalene-1-sulphonamide (HI). It is apparent that comparatively
minor alterations in the chemical structure of the hyperplastic agent (HPA) are
sufficient to suppress its activity. From the limited number ofcompounds tested
it appears that an unsubstituted sulphonamide group is necessary for activity,
because both the monomethyl and the piperidyl-substituted sulphonamides were
inactive. Similarly, the observation that 4-n-propylsulphonyl-naphthalene-l-
sulphonamide was inactive, whereas the isopropyl derivative was active, indicates
that the sulphonyl part of the molecule is also important.
The mechanism of action of these chemicals requires further study. Walpole
and Paget were of the opinion that the hyperplasia might have been induced byHYPERPLASIA OF URINARY TRACT EPITHELIUM 119
the phosphatic crystalluria caused by the hyperplastic aoent (HPA). This seems
unlikely, as both active and inactive compounds lead to crystalluria, and hyper-
plasia of the ureteric and pelvic epithelium occurs when there are no crystals in
the lumen. Moreover, there was no correlation between the presence of con-
cretion in the bladder and hyperplasia of the epithelium.
It remains necessary to determine whether the hyperplastic agent (HPA)
itself or a metabolite is the effective chemical.
The relation of induced hyperplasia to the possible development of cancer
requires further investigation. Occasional papillomas and cancers were observed
among the mice which survived treatment with active compounds for 40 weeks
but otherwise the present experiments do little to illuminate this aspect of the
problem.
SUMMARY
1. 4-Ethylsulphonylnaphthalene-l-sulphonamide (HPA) and six analogues
were tested to observe their effect on theepithelium oftheurinary tract ofdifferent
species of animals. Three of these, namely HPA, 4-methylsulphonylnaphthalene-
I-sulphonamide and 4-isopropylsulphonylnaphthalene-l-sulphonamide were effec-
tive in inducing epithelial hyperplasia which persisted as long as the adminis-
tration of the compounds was continued. The hyperplasia regressed if chemical
treatment was discontinued for a week.
2. The mouse, rat and possibly rabbit were found to be susceptible to such
epithelial hyperplasia. Of the strains of mice tested, Strong A and WLL were
uniform in their response, while the CBA strain was less responsive. There was
no sex difference.
3. The action of the compounds on the renal parenchyma was similar to that
of other sulphonamides. Their mode of action is, however, not yet clarified.
4. These compounds have a great interest in regard to urinary tract carcino-
genesis, but the present experiments were not of sufficient duration to establisli
such an action.
I wish to express my deep sense of gratitude to Dr. G. M. Bonser for her
guidance and encouragement, and to Dr. D. B. Clayson for his close and constant
help throughout the whole period and for the preparation of the chemicals. I am
grateful to Professor H. N. Green for allowing me to work in thedepartment. This
work was carried out during the tenure of a Fellowship under the Colombo Plan.
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